Mitsubishi UFJ Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Mitsubishi UFJ Asset Management's NVAX Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management reduced its Novavax (NVAX) stake by 30% in Q2 2026, selling an estimated $94.8K and leaving 25,162 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.
Mitsubishi UFJ Asset Management first reported a position in NVAX in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.83M in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Mitsubishi UFJ Asset Management held 25,162 shares of Novavax worth $237K as of Q2 2026.
- Mitsubishi UFJ Asset Management sold 10,575 Novavax shares in Q2 2026, an estimated $94.8K.
- Novavax made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1005 holding.
- Mitsubishi UFJ Asset Management first reported a position in Novavax in Q2 2021 and has held it in 21 quarters since.
- Mitsubishi UFJ Asset Management's Novavax position peaked at $3.83M in Q3 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.